• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Brainstorm Health 2021-Moderna-Stephane Bancel
Conferences
Moderna is working toward a single shot for both COVID and flu protection
By Sy MukherjeeApril 27, 2021
One billion COVID vaccines
Newsletters
Would a free water bottle convince you to get a COVID vaccine?
By Sy MukherjeeApril 26, 2021
One billion COVID vaccines
Health
More than 1 billion COVID vaccine doses have been administered around the world
By Sy MukherjeeApril 26, 2021
One billion COVID vaccines
Newsletters
The last mile of the immunization campaign approaches
By Sy Mukherjee and David Z. MorrisApril 23, 2021
Skeptical of outdoor masking? Congratulations on catching up to reality.
Newsletters
Skeptical of outdoor masking? Congratulations on catching up to reality.
By Sy Mukherjee and David Z. MorrisApril 22, 2021
The last mile of the immunization campaign approaches
Newsletters
The last mile of the immunization campaign approaches
By Sy Mukherjee and David Z. MorrisApril 21, 2021
COVID vax supply demand curve
Health
More people have wanted COVID vaccines than were available. That’s about to change
By Sy MukherjeeApril 21, 2021
What’s the matter with Michigan?
Newsletters
What’s the matter with Michigan?
By Sy Mukherjee and David Z. MorrisApril 20, 2021
Cannabis sales pandemic 420
Health
The pandemic created the American cannabis consumer, who’s not going away
By Sy MukherjeeApril 20, 2021
A milestone for COVID vaccinations as all U.S. adults are eligible
Newsletters
A milestone for COVID vaccinations as all U.S. adults are eligible
By Sy Mukherjee and David Z. MorrisApril 19, 2021
Drug development innovation
Newsletters
What makes a drug company truly innovative?
By Sy Mukherjee and David Z. MorrisApril 16, 2021
Johnson and Johnson covid vaccine
Health
Public confidence in the Johnson & Johnson vaccine has dropped. What will it take to restore trust?
By Sy MukherjeeApril 16, 2021
Meet the most innovative and inventive pharmaceutical companies of 2021
Health
Meet the most innovative and inventive pharmaceutical companies of 2021
By Sy Mukherjee and IDEA PharmaApril 16, 2021
Johnson & Johnson: The pause heard ’round the world
Newsletters
Johnson & Johnson: The pause heard ’round the world
By David Z. Morris and Sy MukherjeeApril 15, 2021
Catalent COVID vaccine contract manufacturers
Newsletters
The crucial third party players in the pandemic fight
By David Z. Morris and Sy MukherjeeApril 14, 2021
1...
  • 4
  • 5
  • 6
  • 7
  • 8
...100
Most Popular
Success
Even as Elon Musk calls philanthropy ‘very hard,’ everyday Americans gave a record $617 billion—despite feeling the squeeze over the cost of livingplaceholder alt text
By Preston ForeJuly 4, 2026
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.